Overview
Cronos Group Inc. is a globally recognized cannabis company headquartered in Toronto, Canada. Operating primarily in the burgeoning legal cannabis industry, Cronos Group dedicates itself to cultivating and manufacturing innovative cannabinoid products. Its portfolio includes both recreational and medical marijuana products, distributed across an international market spanning North America, including Canada and the United States, as well as several other countries through strategic partnerships and subsidiaries. A significant aspect of their operations focuses on researching advanced cannabinoid technologies, aiming to enhance and diversify product offerings. Key projects include developing lab-grown cannabis and expanding product lines in CBD-infused wellness and beauty sectors. Through these ventures, Cronos Group seeks to capitalize on the growing acceptance and legalization of cannabis worldwide.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Cronos Group Inc. as of June 30, 2025 is 130.28 MM.
- The operating income for Cronos Group Inc. as of June 30, 2025 is -33.43 MM.
- The net income for Cronos Group Inc. as of June 30, 2025 is 18.49 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 130.28 | -33.43 | 18.49 |
2025-03-31 | 124.59 | -43.89 | 49.44 |
2024-12-31 | 117.61 | -54.27 | 41.08 |
2024-09-30 | 111.23 | -58.71 | -47.44 |
2024-06-30 | 101.78 | -67.43 | -57.43 |
2024-03-31 | 93.03 | -73.03 | -57.03 |
2023-12-31 | 87.24 | -79.91 | -73.96 |
2023-09-30 | 85.36 | -88.62 | -108.06 |
2023-06-30 | 80.96 | -95.22 | -143.40 |
2023-03-31 | 83.54 | -98.92 | -155.26 |
2022-12-31 | 86.75 | -104.39 | -168.73 |
2022-09-30 | 90.51 | -116.26 | -223.49 |
2022-06-30 | 90.51 | -143.80 | -108.58 |
2022-03-31 | 84.53 | -179.70 | -267.43 |
2021-12-31 | 64.56 | -165.53 | -396.11 |
2021-09-30 | 65.69 | -216.61 | -373.70 |
2021-06-30 | 56.64 | -203.29 | -382.59 |
2021-03-31 | 50.90 | -177.79 | -310.49 |
2020-12-31 | 46.72 | -179.39 | -73.14 |
2020-09-30 | 36.98 | -184.51 | 100.10 |
2020-06-30 |
Income Statement: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | 0.11 | 0.11 |
2024-09-30 | -0.12 | -0.12 |
2024-06-30 | -0.15 | -0.15 |
2024-03-31 | -0.15 | -0.15 |
2023-12-31 | -0.19 | -0.19 |
2023-09-30 | -0.28 | -0.29 |
2023-06-30 | -0.38 | -0.38 |
2023-03-31 | -0.41 | -0.42 |
2022-12-31 | -0.45 | -0.45 |
2022-09-30 | -0.59 | -0.60 |
2022-06-30 | -0.29 | -0.29 |
2022-03-31 | -0.72 | -0.72 |
2021-12-31 | -1.07 | |
2021-09-30 | -1.02 | -1.02 |
2021-06-30 | -1.06 | -1.06 |
2021-03-31 | -0.87 | -0.87 |
2020-12-31 | -0.21 | -0.21 |
2020-09-30 | 0.29 | 2.34 |
2020-06-30 | 1.95 | 2.87 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Cronos Group Inc. as of June 30, 2025 is 20.02 MM.
- The cash from investing activities for Cronos Group Inc. as of June 30, 2025 is -62.19 MM.
- The cash from financing activities for Cronos Group Inc. as of June 30, 2025 is -10.94 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 20.02 | -62.19 | -10.94 |
2025-03-31 | 18.95 | -69.76 | -3.52 |
2024-12-31 | 18.84 | 175.15 | -1.23 |
2024-09-30 | 27.94 | 262.07 | -1.14 |
2024-06-30 | 16.17 | 420.46 | -1.15 |
2024-03-31 | 2.65 | 433.87 | -0.93 |
2023-12-31 | -42.84 | -59.50 | -1.03 |
2023-09-30 | -84.02 | 17.07 | -1.43 |
2023-06-30 | -97.22 | -260.49 | -1.65 |
2023-03-31 | -102.73 | -305.75 | -3.18 |
2022-12-31 | -88.95 | -1.84 | -2.90 |
2022-09-30 | -100.51 | -78.96 | -2.56 |
2022-06-30 | -118.61 | 37.34 | -6.57 |
2022-03-31 | -140.91 | -19.08 | -5.24 |
2021-12-31 | -153.62 | -28.90 | -13.44 |
2021-09-30 | -156.01 | -127.90 | -13.88 |
2021-06-30 | -152.69 | -126.21 | -11.96 |
2021-03-31 | -152.59 | -48.65 | -11.27 |
2020-12-31 | -144.87 | 20.15 | -3.05 |
2020-09-30 | -160.02 | 112.15 | 32.41 |
2020-06-30 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 |
Management Effectiveness
- The roa for Cronos Group Inc. as of June 30, 2025 is 0.05.
- The roe for Cronos Group Inc. as of June 30, 2025 is 0.05.
- The roic for Cronos Group Inc. as of June 30, 2025 is 0.04.
- The croic for Cronos Group Inc. as of June 30, 2025 is -0.05.
- The ocroic for Cronos Group Inc. as of June 30, 2025 is 0.02.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | 0.05 | 0.05 | 0.04 | -0.05 | 0.02 |
2025-03-31 | 0.04 | 0.05 | 0.04 | 0.17 | 0.02 |
2024-12-31 | -0.04 | 0.04 | -0.04 | 0.26 | 0.02 |
2024-09-30 | -0.05 | -0.04 | -0.05 | 0.41 | 0.02 |
2024-06-30 | -0.05 | -0.05 | -0.05 | 0.41 | 0.00 |
2024-03-31 | -0.06 | -0.06 | -0.07 | -0.09 | -0.04 |
2023-12-31 | -0.09 | -0.09 | -0.10 | -0.06 | -0.08 |
2023-09-30 | -0.11 | -0.11 | -0.13 | -0.33 | -0.09 |
2023-06-30 | -0.12 | -0.11 | -0.13 | -0.33 | -0.09 |
2023-03-31 | -0.12 | -0.13 | -0.14 | -0.40 | -0.09 |
2022-12-31 | -0.15 | -0.15 | -0.19 | -0.17 | -0.08 |
2022-09-30 | -0.07 | -0.15 | -0.19 | -0.17 | -0.08 |
2022-06-30 | -0.15 | -0.07 | -0.08 | -0.08 | -0.09 |
2022-03-31 | -0.21 | -0.17 | -0.20 | -0.12 | -0.11 |
2021-12-31 | -0.08 | -0.23 | -0.29 | -0.14 | -0.09 |
2021-09-30 | -0.19 | -0.21 | -0.25 | -0.17 | -0.09 |
2021-06-30 | -0.08 | -0.09 | -0.09 | -0.13 | -0.09 |
2021-03-31 | -0.16 | -0.18 | -0.20 | -0.07 | -0.09 |
2020-12-31 | -0.03 | -0.04 | -0.04 | -0.07 | -0.08 |
2020-09-30 | 0.04 | 0.05 | 0.06 | -0.01 | -0.09 |
2020-06-30 | 0.24 | 0.52 | 0.38 | -0.06 | -0.09 |
Gross Margins
- The gross margin for Cronos Group Inc. as of June 30, 2025 is 0.32.
- The net margin for Cronos Group Inc. as of June 30, 2025 is 0.40.
- The operating margin for Cronos Group Inc. as of June 30, 2025 is -0.35.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | 0.32 | 0.40 | -0.35 |
2025-03-31 | 0.26 | 0.35 | -0.46 |
2024-12-31 | 0.21 | -0.43 | -0.53 |
2024-09-30 | 0.16 | -0.56 | -0.66 |
2024-06-30 | 0.14 | -0.61 | -0.79 |
2024-03-31 | 0.14 | -0.85 | -0.92 |
2023-12-31 | 0.09 | -1.19 | -1.11 |
2023-09-30 | 0.08 | -1.67 | -1.24 |
2023-06-30 | 0.09 | -1.67 | -1.24 |
2023-03-31 | 0.13 | -1.78 | -1.25 |
2022-12-31 | 0.15 | -2.36 | -1.32 |
2022-09-30 | 0.13 | -2.36 | -1.32 |
2022-06-30 | -0.09 | -1.15 | -1.59 |
2022-03-31 | -0.24 | -3.08 | -2.11 |
2021-12-31 | -0.62 | -5.32 | -2.65 |
2021-09-30 | -0.62 | -5.69 | -3.15 |
2021-06-30 | -0.62 | -2.59 | -3.42 |
2021-03-31 | -0.44 | -6.10 | -3.30 |
2020-12-31 | -0.55 | -1.57 | -3.84 |
2020-09-30 | -0.84 | 2.71 | -4.99 |
2020-06-30 | -1.04 | 20.23 | -5.54 |
Identifiers and Descriptors
Central Index Key (CIK) | 1656472 |
Industry Groups
SIC 2833 - Medicinal Chemicals and Botanical Products |